In this regard it is pertinent to recall an elegant study from Dr. Egilmez's group, where they showed that enhancing gut barrier integrity by combination treatment with IL-10 and IL-12 sensitizes colon cancer to immunotherapy 93. This evidence concerns the gene IL10 and malignant colon neoplasm.